Should I Buy Cisco Stock? 3 Pros, 3 Cons

Cisco stock is off its 2013 peak and is trying to fight back after the company's name was marred in the NSA spying scandal. For now, should you swoop in on CSCO? Read More

How to Deal with New Cash From Dividend Payments

As a dividend investor, you have the luxury of receiving regular cash infusions on a regular basis. Here are 3 possible ways to put that money to work Read More

Why Qualcomm is a Top 25 Socially Responsible Dividend Stock

Qualcomm has been named a Top 25 Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average DividendRank. Here's why... Read More

Here’s the Very Best Way to Manage Your Dividend Portfolio

The hardest part about investing is actually not doing anything. Yet with the right mix of steady dividend-paying stocks, buy and hold investing still rules Read More

5 High-Yield Dividend Stocks Insiders Love

Dividend stocks are attractive because of their steady stream of payouts. And insider ownership demonstrates confidence in a stock. Why not combine both? Read More

How to Analyze Dividend Stock Investment Opportunities

Finding a dividend stock in which to invest takes more than screening. Investors need to look deeper, and here are some of the ways I analyze dividend stocks Read More

Helmerich & Payne Named Top Dividend Stock (HP)

We looked at the most recent Dividend Channel report, and found Helmerich & Payne showed characteristics that make it a top dividend stock. Find out why here. Read More

BAC Banks a Raise: 5 Dividend Stocks Raising Payouts

Dividend stocks are increasing payouts at a much slower rate, but here are 5 dividend stocks which raised payouts over the past two weeks. Read More

5 Cheap Dividend Stocks to Buy

A low share price isn't always a sign of weakness in cheap stocks. Sometimes a low share price is a gift -- especially when they're for dividend stocks. Read More

When to Buy Dividend-Paying Stocks

Focus on these 5 metrics to help in your analysis of when to buy a dividend paying stock to help crowd out the noise of every day stock watching. Read More

3 European Dividend Stocks to Buy

A combination of plummeting yields in Europe as well as expected stimulus by the ECB could translate into banner years for these dividend stocks. Read More

Why Bristol-Myers Squibb is a Top 25 Dividend Giant (BMY)

Bristol-Myers Squibb has been named as a Top 25 Dividend Giant by ETF Channel, with a staggering $3.09B worth of stock held by ETFs. Read More

JNJ: A Little Leaner, But Is This Dividend Stalwart a Buy?

Johnson & Johnson's Ortho-Clinical sale is a bit of a head-scratcher, but it doesn't change the big picture much. JNJ stock still serves a purpose. Read More

3 Places to Search for Dividend Stock Opportunities

As a dividend stock investor, your goal is to find investments that increase distributions every single year. Here are 3 dividend stock lists that will help Read More

Dividend Stocks Providing for Consistent Cash Income

The beauty of owning a steady dividend stock portfolio is you don't have to keep a 24/7 watch on your portfolio. Here's how dividend stocks keep working for you Read More

50 Blue-Chip Dividend Stocks Increasing Payouts in Q1 2014

These 50 dividend stocks all hiked their regular payouts during the past three months. Here's a look at the new dividend yields, payout dates and more. Read More

Buy Johnson & Johnson Stock For the Yield, Not Growth

Welcome to the Stock of the Day. jnj stock Johnson & JohnsonHealthcare and consumer goods giant Johnson & Johnson (JNJ) is dominating headlines today after it announced plans to sell its diagnostics unit to Carlyle Group (CG) for over $4 billion. Now that Johnson & Johnson is shedding its slow-growing business to focus on more profitable lines, is this a buying opportunity? Find out now. Company Profile Johnson & Johnson is not just a power player in the big pharma industry, it also began as a family company. Founded in 1886, the three Johnson brothers sought to spread the practice of, and become the standard for, sterile surgery in the U.S. That mission continues today, only now, the company maintains this standard worldwide. JNJ has grown to become a $71 billion company, with hundreds of products in more than 170 countries worldwide. Industry Breakdown From oral care, baby care, and skin care products, to over-the-counter medicines, JNJ has a broad consumer reach and relies on its reputation as a trusted family company to market its products and remain a leading competitor in the global pharmaceutical industry. JNJ is first in medical devices, fifth in biologics, sixth in consumer health and eighth in pharmaceuticals. The stock also pays a 2.6% dividend, making it one of the highest in an industry with over 250 players. Looking Ahead Johnson & Johnson is scheduled to report first-quarter results on April 15, but I don't expect it to turn heads. For the current quarter, the analyst community is forecasting $1.48 EPS on $18 billion in sales. Compared with Q1 2013 this would represent 2.8% sales growth and 2.8% earnings growth. Looking ahead to full-year 2014, Johnson & Johnson is expected to post 4% top-line and 5.6% bottom-line growth. Not bad for a 128-year-old company, but also not the kind of earnings I look for in my top blue chip picks. Current Ratings Before you buy any stock, you should always run it through my free Portfolio Grader ratings system. On the fundamentals side, Johnson & Johnson gets a solid B-level rating from me. Johnson & Johnson's strong suits are its operating margin growth (B), earnings growth (B) and return on equity (A) , while its sales growth, earnings momentum and analyst earnings revisions need some work (all Cs). But the reason that I have Johnson & Johnson  stock down at a C-rated hold is because buying pressure, a measure of a stock's risk/return ratio, has tapered off of late. JNJ receives a C for its Quantitative Grade. Bottom Line: As of this posting, March 31, I consider Johnson & Johnson stock  a C-rated Hold. With its solid dividend yield this is a good hold if you already own shares but I wouldn't recommend it for new money at this time. Would you like to check the fundamentals backing up one of your stocks? For more stock grades, please visit my Portfolio Grader website! Read More

How to Identify Your Dividend Stock Investment Goals

After working hard for many years and saving money, you've decided to put it to work with dividend stocks. Here's a starting guide to establishing goals Read More

Line Your Pockets With These 5 Pure-Play REITs

Companies are spinning off assets into separate businesses to enhance valuations -- pure-play REITs are all the rage. Here are five worth considering. Read More

4 High-Yield Small Caps Poised to Rally

Small caps aren't typically known for boasting huge dividend yields, but these four companies are very compelling exceptions to the rule. Read More